Abeo down 12% on gene therapy data in Sanfilippo – Seeking Alpha
ReuropeAbeo down 12% on gene therapy data in SanfilippoSeeking AlphaAbeona Therapeutics (ABEO -11.5%) is down on a 50% spike in volume following its release of updated data from a Phase 1/2 clinical trial assessing gene therapy ABO-102 in patients with… Continue reading
